Tim-3 expression and its role in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common tumors in the world, and its mortality is still on the rise. Limited treatments and low chemotherapy sensitivity of HCC make new therapeutic strategies urgently needed. With the rise of immune checkpoint blockade, anti-CTLA-4 antibodies and an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feifei, Liu, Yanning, Chen, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182863/
https://www.ncbi.nlm.nih.gov/pubmed/30309387
http://dx.doi.org/10.1186/s13045-018-0667-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182863/
https://www.ncbi.nlm.nih.gov/pubmed/30309387
http://dx.doi.org/10.1186/s13045-018-0667-4

Ejemplares similares